CNMD
CONMED Corporation
NYSE · Healthcare · Medical - Devices · US
$49.32
−0.20%Year over year
Reported trailing growth
- Revenue
- +3.6%
- EBITDA
- -23.1%
- EBIT
- -13.6%
- EPS
- -48.0%
- Free cash flow
- -9.3%
- Operating cash flow
- -8.9%
Forward estimates
Based on analyst estimates
- Revenue
- +1.8%
- EBITDA
- +52.0%
- EPS
- +142.0%
Three-year CAGR
- Revenue
- +9.5%
- EBITDA
- +170.6%
- EBIT
- +26.3%
- Net income
- -14.6%
- EPS
- -14.9%
- Free cash flow
- +135.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026